ArticleCancer science2023

YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.

Xuesong Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.